Dhivya Sridaran, Khandelwal Nidhi, Abraham Suresh K, Premkumar Kumpati
Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
Jawaharlal Nehru University, New Delhi, India.
Integr Cancer Ther. 2016 Dec;15(4):525-534. doi: 10.1177/1534735416628344. Epub 2016 May 4.
Hypothesis Anthocyanins possess well-known biological effects and suppress DNA damage induced by therapeutic topoisomerase poisons. Our study focusses on the modulatory effects of anthocyanidins-malvidin (MAL) and pelargonidin (PEL)-on topoisomerase II poison mitoxantrone (MXT)-induced cytotoxicity and genotoxicity in in vitro and in vivo conditions. Study design HepG2 cells were treated with MXT (1-10 µM), MAL (10-100 µM,) and PEL (5-640 µM) to determine cell viability. Further, experiments on cytotoxicity and apoptosis induction by single agents or combinations were performed. In vitro and in vivo antigenotoxic effect of MAL/PEL against MXT was evaluated in human lymphocytes and mouse bone marrow cells. Methods Cytotoxicity of test agents and apoptosis induction in HepG2 cells was assessed by MTT assay, trypan blue dye exclusion assay and Hoechst 33258 staining. Antigenotoxic effects of MAL/PEL against MXT were assessed in co-treated human lymphocytes and bone marrow from mice that received MXT intraperitoneally 30 minutes post MAL/PEL oral administration Results Dose-dependent cytotoxicity was observed with all 3 test agents in HepG2 cells. Highest test concentration of 100 µM MAL, 640 µM PEL, and 10 µM MXT decreased HepG2 cell viability by 80%, 30%, and 90%, respectively. The combination of 1 µM MXT + 80 µM MAL reduced cell viability better than single agents. MAL/PEL treatment significantly reduced MXT-induced genotoxicity in human lymphocytes and micronuclei formation in mice. Conclusion Combination of MAL/PEL with lower doses of MXT, especially MAL+MXT increases the cytotoxicity in cancer cells. In addition, MXT treatment with MAL/PEL reduced MXT-induced genotoxicity and protected normal cells during chemotherapy.
假设 花青素具有众所周知的生物学效应,并能抑制治疗性拓扑异构酶毒物诱导的DNA损伤。我们的研究聚焦于花青素-锦葵色素(MAL)和天竺葵色素(PEL)对拓扑异构酶II毒物米托蒽醌(MXT)在体外和体内条件下诱导的细胞毒性和遗传毒性的调节作用。研究设计 用MXT(1-10µM)、MAL(10-100µM)和PEL(5-640µM)处理HepG2细胞以确定细胞活力。此外,进行了关于单一药物或联合用药的细胞毒性和凋亡诱导实验。在人淋巴细胞和小鼠骨髓细胞中评估了MAL/PEL对MXT的体外和体内抗遗传毒性作用。方法 通过MTT法、台盼蓝染料排斥法和Hoechst 33258染色评估受试药物的细胞毒性以及HepG2细胞中的凋亡诱导情况。在共同处理的人淋巴细胞和口服MAL/PEL 30分钟后腹腔注射MXT的小鼠的骨髓中评估MAL/PEL对MXT的抗遗传毒性作用。结果 在HepG2细胞中观察到所有3种受试药物均呈剂量依赖性细胞毒性。100µM MAL、640µM PEL和10µM MXT的最高测试浓度分别使HepG2细胞活力降低80%、30%和90%。1µM MXT + 80µM MAL联合用药比单一药物更能降低细胞活力。MAL/PEL处理显著降低了MXT在人淋巴细胞中诱导的遗传毒性以及小鼠中的微核形成。结论 MAL/PEL与较低剂量的MXT联合使用,尤其是MAL+MXT可增加癌细胞中的细胞毒性。此外,MXT与MAL/PEL联合治疗可降低MXT诱导的遗传毒性,并在化疗期间保护正常细胞。